CAPLIN POINT LABORATORIES
|
CAPLIN POINT LABORATORIES Last 5 Year Balance Sheet History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
EQUITY AND LIABILITIES | |||||
Share Capital | ₹90 Cr | ₹90 Cr | ₹90 Cr | ₹90 Cr | ₹51 Cr |
Equity - Authorised | ₹17 Cr | ₹17 Cr | ₹17 Cr | ₹17 Cr | ₹17 Cr |
Equity - Issued | ₹15 Cr | ₹15 Cr | ₹15 Cr | ₹15 Cr | ₹15 Cr |
Equity Paid Up | ₹15 Cr | ₹15 Cr | ₹15 Cr | ₹15 Cr | ₹15 Cr |
Equity Shares Forfeited | - | - | - | - | - |
Adjustments to Equity | - | - | - | - | - |
Preference Capital Paid Up | ₹75 Cr | ₹75 Cr | ₹75 Cr | ₹75 Cr | ₹36 Cr |
Face Value | ₹2.00 | ₹2.00 | ₹2.00 | ₹2.00 | ₹2.00 |
Share Warrants & Outstandings | ₹15 Cr | ₹15 Cr | ₹15 Cr | ₹9.44 Cr | ₹6.85 Cr |
Total Reserves | ₹1,775 Cr | ₹1,379 Cr | ₹1,081 Cr | ₹849 Cr | ₹575 Cr |
Securities Premium | ₹155 Cr | ₹150 Cr | ₹146 Cr | ₹146 Cr | ₹71 Cr |
Capital Reserves | ₹3.21 Cr | ₹3.21 Cr | ₹2.86 Cr | ₹2.39 Cr | ₹0.41 Cr |
Profit & Loss Account Balance | ₹1,540 Cr | ₹1,191 Cr | ₹914 Cr | ₹675 Cr | ₹493 Cr |
General Reserves | ₹11 Cr | ₹11 Cr | ₹11 Cr | ₹11 Cr | ₹11 Cr |
Other Reserves | ₹66 Cr | ₹23 Cr | ₹7.23 Cr | ₹14 Cr | ₹-0.08 Cr |
Reserve excluding Revaluation Reserve | ₹1,775 Cr | ₹1,379 Cr | ₹1,081 Cr | ₹849 Cr | ₹575 Cr |
Revaluation reserve | - | - | - | - | - |
Shareholder's Funds | ₹1,880 Cr | ₹1,484 Cr | ₹1,186 Cr | ₹948 Cr | ₹633 Cr |
Minority Interest | ₹27 Cr | ₹26 Cr | ₹18 Cr | ₹8.66 Cr | ₹0.08 Cr |
Long-Term Borrowings | - | - | - | - | - |
Secured Loans | - | - | - | ₹0.02 Cr | ₹0.29 Cr |
Non Convertible Debentures | - | - | - | - | - |
Converible Debentures & Bonds | - | - | - | - | - |
Packing Credit - Bank | - | - | - | - | - |
Inter Corporate & Security Deposit | - | - | - | - | - |
Term Loans - Banks | - | - | - | ₹15 Cr | - |
Term Loans - Institutions | - | - | - | - | - |
Other Secured | - | - | - | ₹-15 Cr | ₹0.29 Cr |
Unsecured Loans | - | - | - | - | - |
Fixed Deposits - Public | - | - | - | - | - |
Loans and advances from subsidiaries | - | - | - | - | - |
Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
Foreign Currency Convertible Notes | - | - | - | - | - |
Long Term Loan in Foreign Currency | - | - | - | - | - |
Loans - Banks | - | - | - | ₹21 Cr | - |
Loans - Govt. | - | - | - | - | - |
Loans - Others | - | - | - | - | - |
Other Unsecured Loan | - | - | - | ₹-21 Cr | - |
Deferred Tax Assets / Liabilities | ₹-14 Cr | ₹-6.21 Cr | ₹1.16 Cr | ₹10 Cr | ₹18 Cr |
Deferred Tax Assets | ₹30 Cr | ₹30 Cr | ₹20 Cr | ₹12 Cr | ₹4.92 Cr |
Deferred Tax Liability | ₹16 Cr | ₹24 Cr | ₹21 Cr | ₹22 Cr | ₹23 Cr |
Other Long Term Liabilities | ₹8.35 Cr | ₹10 Cr | ₹11 Cr | ₹9.51 Cr | ₹5.38 Cr |
Long Term Trade Payables | - | - | - | - | - |
Long Term Provisions | ₹7.78 Cr | ₹8.48 Cr | ₹5.69 Cr | ₹5.23 Cr | ₹0.13 Cr |
Total Non-Current Liabilities | ₹2.30 Cr | ₹13 Cr | ₹17 Cr | ₹25 Cr | ₹23 Cr |
Current Liabilities | - | - | - | - | - |
Trade Payables | ₹164 Cr | ₹156 Cr | ₹89 Cr | ₹64 Cr | ₹60 Cr |
Sundry Creditors | ₹164 Cr | ₹156 Cr | ₹89 Cr | ₹64 Cr | ₹60 Cr |
Acceptances | - | - | - | - | - |
Due to Subsidiaries- Trade Payables | - | - | - | - | - |
Other Current Liabilities | ₹100 Cr | ₹49 Cr | ₹52 Cr | ₹79 Cr | ₹24 Cr |
Bank Overdraft / Short term credit | - | - | - | - | - |
Advances received from customers | ₹23 Cr | ₹5.49 Cr | - | - | - |
Interest Accrued But Not Due | - | - | - | - | - |
Share Application Money | - | - | - | - | - |
Current maturity of Debentures & Bonds | - | - | - | - | - |
Current maturity - Others | - | - | - | - | - |
Other Liabilities | ₹77 Cr | ₹43 Cr | ₹52 Cr | ₹79 Cr | ₹24 Cr |
Short Term Borrowings | ₹3.41 Cr | ₹0.50 Cr | - | - | - |
Secured ST Loans repayable on Demands | - | - | - | - | - |
Working Capital Loans- Sec | - | - | - | - | - |
Buyers Credits - Unsec | - | - | - | - | - |
Commercial Borrowings- Unsec | - | - | - | - | - |
Other Unsecured Loans | ₹3.41 Cr | ₹0.50 Cr | - | - | - |
Short Term Provisions | ₹0.28 Cr | ₹2.56 Cr | ₹2.48 Cr | ₹0.91 Cr | ₹1.44 Cr |
Proposed Equity Dividend | - | - | - | - | - |
Provision for Corporate Dividend Tax | - | - | - | - | - |
Provision for Tax | - | - | - | - | - |
Provision for post retirement benefits | - | - | - | ₹0.91 Cr | ₹1.44 Cr |
Preference Dividend | - | - | - | - | - |
Other Provisions | ₹0.28 Cr | ₹2.56 Cr | ₹2.48 Cr | - | - |
Total Current Liabilities | ₹268 Cr | ₹208 Cr | ₹143 Cr | ₹144 Cr | ₹86 Cr |
Total Liabilities | ₹2,178 Cr | ₹1,730 Cr | ₹1,364 Cr | ₹1,126 Cr | ₹743 Cr |
ASSETS | |||||
Gross Block | ₹480 Cr | ₹446 Cr | ₹423 Cr | ₹355 Cr | ₹272 Cr |
Less: Accumulated Depreciation | ₹201 Cr | ₹159 Cr | ₹117 Cr | ₹82 Cr | ₹45 Cr |
Less: Impairment of Assets | - | - | - | - | - |
Net Block | ₹280 Cr | ₹287 Cr | ₹305 Cr | ₹273 Cr | ₹227 Cr |
Lease Adjustment A/c | - | - | - | - | - |
Capital Work in Progress | ₹220 Cr | ₹15 Cr | ₹14 Cr | ₹20 Cr | ₹9.70 Cr |
Non Current Investments | ₹71 Cr | ₹37 Cr | ₹0.66 Cr | ₹0.56 Cr | ₹0.33 Cr |
Long Term Investment | ₹71 Cr | ₹37 Cr | ₹0.66 Cr | ₹0.56 Cr | ₹0.33 Cr |
Quoted | ₹0.74 Cr | ₹0.60 Cr | ₹0.66 Cr | ₹0.33 Cr | ₹0.33 Cr |
Unquoted | ₹70 Cr | ₹36 Cr | - | ₹0.23 Cr | ₹0.00 Cr |
Long Term Loans & Advances | ₹52 Cr | ₹90 Cr | ₹7.92 Cr | ₹10 Cr | ₹12 Cr |
Other Non Current Assets | ₹0.39 Cr | ₹1.08 Cr | ₹21 Cr | - | - |
Total Non-Current Assets | ₹623 Cr | ₹432 Cr | ₹349 Cr | ₹303 Cr | ₹249 Cr |
Current Assets Loans & Advances | - | - | - | - | - |
Currents Investments | ₹159 Cr | ₹52 Cr | ₹11 Cr | ₹60 Cr | ₹70 Cr |
Quoted | ₹20 Cr | ₹52 Cr | - | - | - |
Unquoted | ₹139 Cr | - | ₹11 Cr | ₹60 Cr | ₹70 Cr |
Inventories | ₹288 Cr | ₹227 Cr | ₹179 Cr | ₹238 Cr | ₹37 Cr |
Raw Materials | ₹39 Cr | ₹32 Cr | ₹22 Cr | ₹9.81 Cr | ₹10 Cr |
Work-in Progress | ₹8.88 Cr | ₹6.67 Cr | ₹3.09 Cr | ₹2.30 Cr | ₹3.67 Cr |
Finished Goods | ₹14 Cr | ₹18 Cr | ₹4.73 Cr | ₹7.20 Cr | ₹1.02 Cr |
Packing Materials | ₹28 Cr | ₹21 Cr | ₹20 Cr | ₹13 Cr | ₹7.26 Cr |
Stores Ā and Spare | ₹13 Cr | ₹13 Cr | ₹7.31 Cr | ₹3.93 Cr | ₹3.06 Cr |
Other Inventory | ₹186 Cr | ₹137 Cr | ₹122 Cr | ₹202 Cr | ₹12 Cr |
Sundry Debtors | ₹394 Cr | ₹317 Cr | ₹279 Cr | ₹229 Cr | ₹160 Cr |
Debtors more than Six months | ₹3.78 Cr | - | - | - | - |
Debtors Others | ₹390 Cr | ₹317 Cr | ₹279 Cr | ₹229 Cr | ₹160 Cr |
Cash and Bank | ₹493 Cr | ₹463 Cr | ₹438 Cr | ₹223 Cr | ₹153 Cr |
Cash in hand | ₹1.49 Cr | ₹2.54 Cr | ₹2.66 Cr | ₹3.31 Cr | ₹1.05 Cr |
Balances at Bank | ₹492 Cr | ₹460 Cr | ₹436 Cr | ₹220 Cr | ₹152 Cr |
Other cash and bank balances | - | - | - | - | - |
Other Current Assets | ₹27 Cr | ₹17 Cr | ₹20 Cr | ₹15 Cr | ₹9.22 Cr |
Interest accrued on Investments | ₹21 Cr | ₹12 Cr | ₹8.44 Cr | ₹3.38 Cr | ₹0.95 Cr |
Interest accrued on Debentures | - | - | - | - | - |
Deposits with Government | - | - | - | - | - |
Interest accrued and or due on loans | - | - | - | - | - |
Prepaid Expenses | - | - | - | - | - |
Other current_assets | ₹6.40 Cr | ₹4.94 Cr | ₹12 Cr | ₹11 Cr | ₹8.27 Cr |
Short Term Loans and Advances | ₹192 Cr | ₹221 Cr | ₹87 Cr | ₹57 Cr | ₹65 Cr |
Advances recoverable in cash or in kind | ₹70 Cr | ₹59 Cr | ₹42 Cr | ₹28 Cr | ₹49 Cr |
Advance income tax and TDS | - | - | - | - | - |
Amounts due from directors | - | - | - | - | - |
Due From Subsidiaries | - | - | - | - | - |
Inter corporate deposits | ₹51 Cr | ₹119 Cr | - | - | - |
Corporate Deposits | - | - | - | - | - |
Other Loans & Advances | ₹71 Cr | ₹44 Cr | ₹45 Cr | ₹29 Cr | ₹16 Cr |
Total Current Assets | ₹1,554 Cr | ₹1,298 Cr | ₹1,015 Cr | ₹823 Cr | ₹494 Cr |
Net Current Assets (Including Current Investments) | ₹1,286 Cr | ₹1,090 Cr | ₹872 Cr | ₹678 Cr | ₹408 Cr |
Miscellaneous Expenses not written off | - | - | - | - | - |
Total Assets | ₹2,178 Cr | ₹1,730 Cr | ₹1,364 Cr | ₹1,126 Cr | ₹743 Cr |
Contingent Liabilities | ₹0.64 Cr | ₹0.71 Cr | ₹1.02 Cr | ₹1.28 Cr | ₹1.26 Cr |
Total Debt | ₹3.41 Cr | ₹0.50 Cr | ₹17 Cr | ₹36 Cr | ₹0.54 Cr |
Book Value | - | 184.75 | 144.94 | 114.21 | 78.03 |
Adjusted Book Value | 235.91 | 183.89 | 144.94 | 114.21 | 78.03 |
Compare Balance Sheet of peers of CAPLIN POINT LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CAPLIN POINT LABORATORIES | ₹10,103.0 Cr | -1.9% | 1.1% | 101.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹364,315.0 Cr | -0.1% | -6.3% | 53.5% | Stock Analytics | |
CIPLA | ₹114,614.0 Cr | 1% | -5% | 53.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹105,233.0 Cr | 3.2% | 15.3% | 23.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,900.0 Cr | 1.1% | 2.2% | 26% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹99,426.0 Cr | 3.9% | -1.7% | 85.2% | Stock Analytics |
CAPLIN POINT LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CAPLIN POINT LABORATORIES | -1.9% |
1.1% |
101.7% |
SENSEX | 1% |
2.2% |
23.7% |
You may also like the below Video Courses